05/07/2024
7:00 AM | Fusion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:30 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:52 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
6:54 AM | Fusion Pharmaceuticals (Filer)
| Form DEFA14A | |
04/23/2024
6:34 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/23/2024
6:36 AM | Fusion Pharmaceuticals (Filer)
| Form DEFA14A | |
04/12/2024
4:02 PM | Fusion Pharmaceuticals (Filer)
| Form 8-K/A | |
|
04/12/2024
7:00 AM | Fusion Pharmaceuticals (Filer)
| Form 10-K/A | |
04/10/2024
3:42 PM | Fusion Pharmaceuticals (Filer)
| Form PREM14A | |
04/09/2024
3:10 PM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2024
8:10 AM | FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13G/A | |
03/25/2024
4:29 PM | FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13D | |
03/20/2024
5:08 PM | Fusion Pharmaceuticals (Subject)
HealthCap VII, L.P. (Filed by)
| Form SC 13D/A | |
03/20/2024
3:30 PM | Fusion Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/20/2024
3:10 PM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
3:14 PM | Fusion Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/19/2024
4:27 PM | ASTRAZENECA PLC (Filed by)
ASTRAZENECA PLC (Filed by)
Fusion Pharmaceuticals (Subject)
| Form DFAN14A | |
03/19/2024
5:24 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/19/2024
5:25 AM | Fusion Pharmaceuticals (Filer)
| Form DEFA14A | |
02/13/2024
8:34 PM | Avidity Partners Management LP (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/19/2024
3:37 PM | Fusion Pharmaceuticals (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G | |
01/19/2024
3:10 PM | Fusion Pharmaceuticals (Filer)
| Form 424B5 | |
01/18/2024
9:11 AM | FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/05/2024
7:46 AM | Bobilev Dmitri (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
7:49 AM | Fusion Pharmaceuticals (Issuer)
Rawat Mohit (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
7:51 AM | Burak Eric (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
7:52 AM | Crowley John J (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
7:54 AM | Fusion Pharmaceuticals (Issuer)
Leamon Christopher P (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
7:41 AM | Fusion Pharmaceuticals (Issuer)
Valliant John (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
3:45 PM | Flynn James E (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13G | |
12/14/2023
4:31 PM | Fusion Pharmaceuticals (Subject)
Khuong Chau Quang (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/08/2023
4:36 PM | Fusion Pharmaceuticals (Subject)
Khuong Chau Quang (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2023
7:00 AM | Fusion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2023
6:45 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/23/2023
4:20 PM | Avidity Partners Management LP (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13G | |
10/16/2023
3:59 PM | Bitetti Teresa Marie (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
4:00 PM | Fusion Pharmaceuticals (Issuer)
Meek David D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2023
3:48 PM | Bender Jeremy (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
3:51 PM | Fusion Pharmaceuticals (Issuer)
Meek David D. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
10/16/2023
3:30 PM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2023
7:21 AM | Fusion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
The Crypto 9-5 Escape Plan (Ad) A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market. Click here to get instant access to the guide |
08/08/2023
6:30 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2023
11:15 PM | Fusion Pharmaceuticals (Filer)
| Form EFFECT | |
06/20/2023
7:00 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
4:04 PM | Bergstrom Donald A (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:05 PM | CAGNONI PABLO J (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:06 PM | Duncan Barbara Gayle (Reporting)
Fusion Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:07 PM | Fusion Pharmaceuticals (Issuer)
GANNON STEVEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:08 PM | Fusion Pharmaceuticals (Issuer)
Khuong Chau Quang (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:09 PM | Fusion Pharmaceuticals (Issuer)
Lee Philina (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2023
4:10 PM | Fusion Pharmaceuticals (Issuer)
Preston Heather (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
7:19 AM | FEDERATED HERMES, INC. (Filed by)
FEDERATED HERMES, INC. (Filed by)
Fusion Pharmaceuticals (Subject)
| Form SC 13G/A | |
05/16/2023
3:28 PM | Fusion Pharmaceuticals (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13D/A | |
05/11/2023
7:01 AM | Fusion Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
6:46 AM | Fusion Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
